A Population-based Study of Survival Impact of New Targeted and Immune-based Therapies for Metastatic or Unresectable Melanoma
Author:
Funder
Canadian Institutes of Health Research Operating Grant
Ontario Ministry of Health and Long-Term Care (MOHLTC)
Publisher
Elsevier BV
Subject
Radiology Nuclear Medicine and imaging,Oncology
Reference18 articles.
1. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;New Engl J Med,2010
2. Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma;Schadendorf;J Clin Oncol,2015
3. Five-year survival rates for treatment-naive patients with advanced melanoma who received ipilimumab plus dacarbazine in a phase III trial;Maio;J Clin Oncol,2015
4. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;Chapman;New Engl J Med,2011
5. Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial;Ascierto;Lancet Oncol,2016
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. lnsights into Adjuvant Systemic Treatment Selection for Patients with Stage III Melanoma: Data from the Dutch Cancer Registry;Targeted Oncology;2024-08-24
2. Changes in Health Care Costs, Survival, and Time Toxicity in the Era of Immunotherapy and Targeted Systemic Therapy for Melanoma;JAMA Dermatology;2023-11-01
3. Efficacy of immune checkpoint inhibition in metastatic uveal melanoma: a systematic review and meta-analysis;Melanoma Research;2023-05-18
4. Understanding Real-World Treatment Patterns and Clinical Outcomes among Metastatic Melanoma Patients in Alberta, Canada;Current Oncology;2023-04-13
5. Chemotherapy in Cutaneous Melanoma: Is There Still a Role?;Current Oncology Reports;2023-03-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3